Terms ending in 2037
Every in-force patent on Celltech R&D Limited's record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,136,310 | Iminotetrahydropyrimidinone Derivatives as Plasmepsin V Inhibitors In force · High confidence | Ucb Biopharma SRL | In force | High confidence | |
| US 10,464,932 | Iminothiadiazinane Dioxide Derivatives as Plasmepsin V Inhibitors In force · High confidence | Ucb Biopharma SPRL | In force | High confidence | |
| US 10,654,861 | Fused Pentacyclic Imidazole Derivatives as Modulators of TNF Activity In force · High confidence | Ucb Biopharma SRL | In force | High confidence | |
| US 10,766,906 | Fused Hexacyclic Imidazole Derivatives as Modulators of TNF Activity In force · High confidence | Ucb Biopharma SRL | In force | High confidence | |
| US 11,912,721 | Fused Pentacyclic Imidazole Derivatives In force · High confidence | Sanofi and Ucb Biopharma SPRL | In force | High confidence | |
| US 11,014,962 | Method for Protein Purification In force · High confidence | Ucb Biopharma SRL | In force | High confidence | |
| US 10,842,884 | Endosomolytic Agents for Gene Therapy In force · High confidence | Ucb Biopharma SRL (Ucb Biopharma Societe a Responsabilite Limitee) | In force | High confidence | |
| US 10,947,304 | GREMLIN-1 Antibody In force · High confidence | Ucb Biopharma SRL | In force | High confidence |
8 of 8 patents shown. Soonest term end first, then patent number.
1 of these is in force and held by Celltech R&D Limited.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.